TD Cowen Cuts Procter & Gamble (NYSE:PG) Price Target to $150.00
by Renee Jackson · The Cerbat GemProcter & Gamble (NYSE:PG – Get Free Report) had its price objective reduced by analysts at TD Cowen from $168.00 to $150.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. TD Cowen’s price target points to a potential upside of 5.91% from the stock’s previous close.
Other analysts also recently issued reports about the company. Jefferies Financial Group upgraded Procter & Gamble from a “hold” rating to a “buy” rating and increased their price objective for the company from $156.00 to $179.00 in a report on Tuesday, December 16th. JPMorgan Chase & Co. reduced their price target on Procter & Gamble from $165.00 to $157.00 and set a “neutral” rating on the stock in a research report on Thursday, December 18th. Dbs Bank upgraded Procter & Gamble to a “hold” rating in a research report on Friday, December 5th. Barclays reduced their target price on Procter & Gamble from $153.00 to $151.00 and set an “equal weight” rating on the stock in a report on Monday, December 8th. Finally, Piper Sandler began coverage on shares of Procter & Gamble in a report on Wednesday. They set a “neutral” rating and a $150.00 price target for the company. Fifteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus price target of $169.23.
Get Our Latest Report on Procter & Gamble
Procter & Gamble Trading Up 2.6%
Shares of NYSE:PG traded up $3.59 during midday trading on Thursday, hitting $141.63. 5,793,560 shares of the stock were exchanged, compared to its average volume of 10,310,461. The business’s 50-day moving average price is $145.27 and its 200 day moving average price is $151.77. Procter & Gamble has a 12 month low of $137.62 and a 12 month high of $179.99. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71. The stock has a market capitalization of $330.94 billion, a price-to-earnings ratio of 20.69, a P/E/G ratio of 4.71 and a beta of 0.39.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The business had revenue of $22.39 billion during the quarter, compared to analyst estimates of $22.23 billion. During the same quarter last year, the business earned $1.93 EPS. The firm’s quarterly revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Analysts predict that Procter & Gamble will post 6.91 earnings per share for the current year.
Insider Activity
In other news, CAO Matthew W. Janzaruk sold 725 shares of the firm’s stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $149.57, for a total value of $108,438.25. Following the completion of the sale, the chief accounting officer directly owned 979 shares in the company, valued at $146,429.03. This trade represents a 42.55% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 0.20% of the stock is owned by company insiders.
Institutional Investors Weigh In On Procter & Gamble
Hedge funds have recently added to or reduced their stakes in the company. Halbert Hargrove Global Advisors LLC bought a new stake in shares of Procter & Gamble during the third quarter worth about $25,000. Nova Wealth Management Inc. bought a new stake in Procter & Gamble during the 1st quarter worth approximately $26,000. Signature Resources Capital Management LLC raised its stake in shares of Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after purchasing an additional 72 shares during the last quarter. Saranac Partners Ltd bought a new position in shares of Procter & Gamble in the third quarter valued at approximately $30,000. Finally, Corundum Trust Company INC purchased a new position in shares of Procter & Gamble during the third quarter valued at approximately $32,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Stories
- Five stocks we like better than Procter & Gamble
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
- YDES Could Be 2026’s Biotech Breakthrough
- A Message From An Ex-CIA Officer About Trump
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps